UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934

or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0104

Estimated average burden

hours per response:

0.5

1. Name and Address of Reporting Person*JPMORGAN CHASE & CO

(Last)

(First)

(Middle)

270 PARK AVENUE

(Street)

NEW YORK

NY

(City)

(State)

(Zip)

2. Date of Event Requiring Statement

(Month/Day/Year)

01/25/2018

3. Issuer Name and Ticker or Trading Symbol

Solid Biosciences, LLC

[ SLDB ]

4. Relationship of Reporting Person(s) to Issuer

(Check all applicable)

Director

10% Owner

Officer (give title below)

Other (specify below)

5. If Amendment, Date of Original Filed

(Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

Form filed by One Reporting Person

Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned

1. Title of Security (Instr.

4)

2.

Amount of Securities Beneficially Owned (Instr.

4)

3. Ownership Form: Direct (D) or Indirect (I) (Instr.

5)

4. Nature of Indirect Beneficial Ownership (Instr.

5)

Common Stock

3,031,601

See Footnote(1)(2)

Table II - Derivative Securities Beneficially Owned

(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr.

4)

2. Date Exercisable and Expiration Date

(Month/Day/Year)

3. Title and Amount of Securities Underlying Derivative Security (Instr.

4)

4. Conversion or Exercise Price of Derivative Security

5. Ownership Form: Direct (D) or Indirect (I) (Instr.

5)

6. Nature of Indirect Beneficial Ownership (Instr.

5)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

1. Name and Address of Reporting Person*JPMORGAN CHASE & CO

(Last)

(First)

(Middle)

270 PARK AVENUE

(Street)

NEW YORK

NY

(City)

(State)

(Zip)

Relationship of Reporting Person(s) to Issuer

Director

10% Owner

Officer (give title below)

Other (specify below)

1. Name and Address of Reporting Person*JPMC Strategic Investments II Corp

(Last)

(First)

(Middle)

270 PARK AVENUE

(Street)

NEW YORK

NY

10017

(City)

(State)

(Zip)

Relationship of Reporting Person(s) to Issuer

Director

10% Owner

Officer (give title below)

Other (specify below)

Explanation of Responses:

1. JPMC Strategic Investments II Corporation is the record holder of 3,031,601 shares of Common Stock. JPMC Strategic Investments II Corporation is a wholly-owned subsidiary of JPMorgan Chase & Co., a publicly traded entity listed on the New York Stock Exchange.

2. Upon the consummation of the initial public offering of Solid Biosciences Inc., the reporting persons will own less than 10% of the outstanding shares of Common Stock of Solid Biosciences.

Remarks:

JPMorgan Chase & Co., By: /s/ Michael Lees, Executive Director

01/25/2018

JPMC Strategic Investments II Corporation, By: /s/ Ana Capella Gomez-Acebo, Managing Director

01/25/2018

** Signature of Reporting Person

Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person,

see

Instruction

(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations

See

18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,

see

Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.